1
|
Kao AS, King AD, Bardhi R, Daveluy S. Targeted therapy with ixekizumab in pyoderma gangrenosum: A case series and a literature overview. JAAD Case Rep 2023; 37:49-53. [PMID: 37492426 PMCID: PMC10363659 DOI: 10.1016/j.jdcr.2023.05.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/27/2023] Open
Affiliation(s)
- Andrew S. Kao
- Wayne State University School of Medicine, Detroit, Michigan
| | - Andrew D. King
- Department of Dermatology, Wayne State University School of Medicine, Detroit, Michigan
| | - Redina Bardhi
- Wayne State University School of Medicine, Detroit, Michigan
| | - Steven Daveluy
- Department of Dermatology, Wayne State University School of Medicine, Detroit, Michigan
| |
Collapse
|
2
|
Maghfour J, Bardhi R, Huggins R, Hamzavi IH, Mohammad TF. Recipient-to-Donor Ratios in the Surgical Treatment of Vitiligo, Leukoderma, and Piebaldism: A Retrospective Review. Dermatology 2023; 239:828-831. [PMID: 37231873 DOI: 10.1159/000530930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2022] [Accepted: 04/25/2023] [Indexed: 05/27/2023] Open
Abstract
BACKGROUND The autologous noncultured melanocyte keratinocyte transplant procedure (MKTP) has emerged as a popular grafting technique with proven efficacy for achieving repigmentation. However, there remains no consensus regarding the optimal recipient-to-donor (RD) ratio required to achieve acceptable repigmentation. In this retrospective cohort study of 120 patients, we sought to examine whether expansion ratios impact the repigmentation success rates following MKTP. RESULTS A total of 69 patients (mean [SD] age was 32.4 [14.3] years, mean follow-up was 30.4 [22.5] months, 63.8% were male; 55% were dark-skinned individuals [Fitzpatrick IV-VI]) were included. The mean percent change in the Vitiligo Area Scoring Index (VASI) was 80.2 (±23.7; RD of 7.3) in patients with focal/segmental vitiligo (SV), 58.3 (±33.0; RD of 8.2) in those with non-segmental vitiligo (NSV), and 51.8 (±33.6; RD of 3.7) in those with leukoderma and piebaldism. Focal/SV was positively associated with a higher percent change in VASI (parameter estimate: 22.6, p value <0.005). In the SV/focal group, non-white patients had a higher RD ratio compared to White individuals (8.2 ± 3.4 vs. 6.0 ± 3.1, respectively, p value = 0.035). DISCUSSION In our study, we found that patients with SV were significantly more likely to achieve higher repigmentation rates compared to those with NSV. Although repigmentation rates were higher in the low expansion ratio group than in the high expansion ratio group, we did not observe a significant difference between the two groups. CONCLUSION MKTP is an effective therapy for restoring repigmentation in patients with stable vitiligo. Therapeutic response of vitiligo to MKTP appears to be influenced by the type of vitiligo, rather than a specific RD ratio.
Collapse
Affiliation(s)
- Jalal Maghfour
- Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA,
| | - Redina Bardhi
- Department of Transitional Year, ProMedica Monroe Regional Hospital, Monroe, Michigan, USA
| | - Richard Huggins
- Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA
| | - Iltefat H Hamzavi
- Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA
| | - Tasneem F Mohammad
- Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA
| |
Collapse
|
3
|
Bardhi R, Musa A, Daveluy S, Potts G. Sophomore Signaling: The Second Year of the ERAS Supplemental Application for Dermatology Residency. J Clin Aesthet Dermatol 2023; 16:26-27. [PMID: 37077929 PMCID: PMC10110290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 04/21/2023]
Abstract
The sophomore year of the supplemental application remains largely unchanged for applicants to dermatology residency. Both program preferences and geographic preferences, although optional, may strongly benefit applicants based on the evidence following the first application cycle. They may greatly improve the residency application process with continued refinements.
Collapse
Affiliation(s)
- Redina Bardhi
- Drs. Bardhi and Musa are with a Transitional Year Residency Program at ProMedica Monroe Regional Hospital in Monroe, Michigan
| | - Arif Musa
- Drs. Bardhi and Musa are with a Transitional Year Residency Program at ProMedica Monroe Regional Hospital in Monroe, Michigan
| | - Steven Daveluy
- Drs. Daveluy and Potts are with the Department of Dermatology at Wayne State University in Dearborn, Michigan
| | - Geoffrey Potts
- Drs. Daveluy and Potts are with the Department of Dermatology at Wayne State University in Dearborn, Michigan
| |
Collapse
|
4
|
Jairath NK, Bardhi R, Runge JS, Bledea R, Jairath R, Wang Y, Patrick M, Wilcox RA, Hristov AC, Tsoi LC, Tejasvi T. Predictors of large cell transformation in patients with Sezary Syndrome-A retrospective analysis. PLoS One 2022; 17:e0277655. [PMID: 36383618 PMCID: PMC9668185 DOI: 10.1371/journal.pone.0277655] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2022] [Accepted: 11/01/2022] [Indexed: 11/17/2022] Open
Abstract
BACKGROUND Large cell transformation (LCT) of Sezary Syndrome (SS) is a rare phenomenon. To date, there are no rigorous studies identifying risk factors for its development. OBJECTIVES Here, we seek to characterize the clinicopathologic risk factors that predispose patients with SS to develop LCT. METHODS We retrospectively evaluated all SS patient records available in the Michigan Medicine Cancer Registry from 2010-2021. Clinical and pathologic variables were compared between groups. The Kaplan-Meier method and log-rank test were used to assess overall survival. RESULTS Of 28 SS patients identified, eight patients experienced LCT, and 20 did not (NLCT). Peak lactate dehydrogenase (LDH) before LCT (p = 0.0012), maximum total body surface area (TBSA) involvement before LCT (p = 0.0114), absolute CD8+ cell count measured on flow cytometry at diagnosis of SS (p = 0.0455) and at the most recent blood draw (p = 0.00736), and ulceration on biopsy (p = 0.0034) were significant clinicopathologic variables identified between the SS patients that developed LCT versus those that did not. CONCLUSIONS Maximum TBSA involvement, peak LDH, presence of ulceration, and decreased levels of CD8+ cells in the peripheral blood may predict the development of LCT in patients with SS.
Collapse
Affiliation(s)
- Neil K. Jairath
- Department of Dermatology, University of Michigan, Ann Arbor, MI, United States of America
| | - Redina Bardhi
- Department of Dermatology, Wayne State University, Detroit, MI, United States of America
| | - John S. Runge
- Department of Dermatology, University of Michigan, Ann Arbor, MI, United States of America
| | - Ramona Bledea
- Department of Dermatology, University of Michigan, Ann Arbor, MI, United States of America
| | - Ruple Jairath
- Department of Dermatology, University of Michigan, Ann Arbor, MI, United States of America
| | - Yang Wang
- Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China
| | - Matthew Patrick
- Department of Dermatology, University of Michigan, Ann Arbor, MI, United States of America
| | - Ryan A. Wilcox
- Department of Hematology and Oncology, University of Michigan, Ann Arbor, MI, United States of America
| | - Alexandra C. Hristov
- Department of Dermatology, University of Michigan, Ann Arbor, MI, United States of America
- Department of Pathology, University of Michigan, Ann Arbor, MI, United States of America
| | - Lam C. Tsoi
- Department of Dermatology, University of Michigan, Ann Arbor, MI, United States of America
- Department of Computational Medicine and Bioinformatics, Department of Biostatistics, University of Michigan, Ann Arbor, MI, United States of America
| | - Trilokraj Tejasvi
- Department of Dermatology, University of Michigan, Ann Arbor, MI, United States of America
- Veteran Affairs Health System, Ann Arbor, MI, United States of America
- * E-mail:
| |
Collapse
|
5
|
King AD, Kao AS, Bardhi R. 34181 Consultation of other services delays dermatologic care for inpatient skin disease. J Am Acad Dermatol 2022. [DOI: 10.1016/j.jaad.2022.06.176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
6
|
Patrick MT, Bardhi R, Zhou W, Elder JT, Gudjonsson JE, Tsoi LC. Enhanced rare disease mapping for phenome-wide genetic association in the UK Biobank. Genome Med 2022; 14:85. [PMID: 35945607 PMCID: PMC9364550 DOI: 10.1186/s13073-022-01094-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2022] [Accepted: 07/21/2022] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND Rare diseases collectively affect up to 10% of the population, but often lack effective treatment, and typically little is known about their pathophysiology. Major challenges include suboptimal phenotype mapping and limited statistical power. Population biobanks, such as the UK Biobank, recruit many individuals who can be affected by rare diseases; however, investigation into their utility for rare disease research remains limited. We hypothesized the UK Biobank can be used as a unique population assay for rare diseases in the general population. METHODS We constructed a consensus mapping between ICD-10 codes and ORPHA codes for rare diseases, then identified individuals with each rare condition in the UK Biobank, and investigated their age at recruitment, sex bias, and comorbidity distributions. Using exome sequencing data from 167,246 individuals of European ancestry, we performed genetic association controlling for case/control imbalance (SAIGE) to identify potential rare pathogenic variants for each disease. RESULTS Using our mapping approach, we identified and characterized 420 rare diseases affecting 23,575 individuals in the UK Biobank. Significant genetic associations included JAK2 V617F for immune thrombocytopenic purpura (p = 1.24 × 10-13) and a novel CALR loss of function variant for essential thrombocythemia (p = 1.59 × 10-13). We constructed an interactive resource highlighting demographic information ( http://www-personal.umich.edu/~mattpat/rareDiseases.html ) and demonstrate transferability by applying our mapping to a medical claims database. CONCLUSIONS Enhanced disease mapping and increased power from population biobanks can elucidate the demographics and genetic associations for rare diseases.
Collapse
Affiliation(s)
- Matthew T Patrick
- Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA.
| | - Redina Bardhi
- Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA.,School of Medicine, Wayne State University, Detroit, MI, USA
| | - Wei Zhou
- Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.,Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA.,Stanley Center for Psychiatric Research, Broad Institute of Harvard and MIT, Cambridge, MA, USA
| | - James T Elder
- Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA
| | - Johann E Gudjonsson
- Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA
| | - Lam C Tsoi
- Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, USA. .,Department of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA. .,Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
| |
Collapse
|
7
|
Runge JS, Bardhi R, Xia Y, Jairath NK, Wilcox RA, Tsoi LC, Tejasvi T. Clinical outcomes in a cohort of patients with cutaneous T cell lymphoma and COVID-19. JAAD Int 2022; 8:52-55. [PMID: 35529773 PMCID: PMC9061130 DOI: 10.1016/j.jdin.2022.04.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
|
8
|
Bardhi R, Adlam T, St Claire K, Utz Petry S, Moossavi M. Dermatomal eruption as the first clinical manifestation of recurrent metastatic pancreatic cancer. JAAD Case Rep 2021; 18:37-39. [PMID: 34805470 PMCID: PMC8590034 DOI: 10.1016/j.jdcr.2021.10.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
Affiliation(s)
- Redina Bardhi
- School of Medicine, Wayne State University, Detroit, Michigan
| | - Taylor Adlam
- Department of Dermatology, Wayne State University, Detroit, Michigan
| | - Kayla St Claire
- Department of Dermatology, Wayne State University, Detroit, Michigan
| | - Sarah Utz Petry
- Department of Dermatology, Wayne State University, Detroit, Michigan
| | - Meena Moossavi
- Department of Dermatology, Wayne State University, Detroit, Michigan
| |
Collapse
|
9
|
Patrick MT, Bardhi R, Raja K, He K, Tsoi LC. Advancement in predicting interactions between drugs used to treat psoriasis and its comorbidities by integrating molecular and clinical resources. J Am Med Inform Assoc 2021; 28:1159-1167. [PMID: 33544847 DOI: 10.1093/jamia/ocaa335] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2020] [Accepted: 12/14/2020] [Indexed: 12/18/2022] Open
Abstract
OBJECTIVE Drug-drug interactions (DDIs) can result in adverse and potentially life-threatening health consequences; however, it is challenging to predict potential DDIs in advance. We introduce a new computational approach to comprehensively assess the drug pairs which may be involved in specific DDI types by combining information from large-scale gene expression (984 transcriptomic datasets), molecular structure (2159 drugs), and medical claims (150 million patients). MATERIALS AND METHODS Features were integrated using ensemble machine learning techniques, and we evaluated the DDIs predicted with a large hospital-based medical records dataset. Our pipeline integrates information from >30 different resources, including >10 000 drugs and >1.7 million drug-gene pairs. We applied our technique to predict interactions between 37 611 drug pairs used to treat psoriasis and its comorbidities. RESULTS Our approach achieves >0.9 area under the receiver operator curve (AUROC) for differentiating 11 861 known DDIs from 25 750 non-DDI drug pairs. Significantly, we demonstrate that the novel DDIs we predict can be confirmed through independent data sources and supported using clinical medical records. CONCLUSIONS By applying machine learning and taking advantage of molecular, genomic, and health record data, we are able to accurately predict potential new DDIs that can have an impact on public health.
Collapse
Affiliation(s)
- Matthew T Patrick
- Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA
| | - Redina Bardhi
- Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA.,School of Medicine, Wayne State University, Detroit, Michigan, USA
| | - Kalpana Raja
- Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA.,Morgridge Institute for Research, Madison, Wisconsin, USA
| | - Kevin He
- Department of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan, USA
| | - Lam C Tsoi
- Department of Dermatology, University of Michigan Medical School, Ann Arbor, Michigan, USA.,Department of Biostatistics, Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan, USA.,Department of Computational Medicine & Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA
| |
Collapse
|
10
|
Farshchian M, Bardhi R, Daveluy S. Desquamative skin rash associated with temozolomide in a patient with glioblastoma. Dermatol Ther 2021; 34:e14771. [PMID: 33421249 DOI: 10.1111/dth.14771] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2020] [Accepted: 12/31/2020] [Indexed: 11/25/2022]
Affiliation(s)
- Mehdi Farshchian
- Department of Dermatology, Wayne State University, Detroit, Michigan, USA
| | - Redina Bardhi
- Wayne State University School of Medicine, Detroit, Michigan, USA
| | - Steven Daveluy
- Department of Dermatology, Wayne State University, Detroit, Michigan, USA
| |
Collapse
|
11
|
Abstract
Normobaric oxygen therapy has gained attention as a simple and convenient means of achieving neuroprotection against the pathogenic cascade initiated by acute ischemic stroke. The mechanisms underlying the neuroprotective efficacy of normobaric oxygen therapy, however, have not been fully elucidated. It is hypothesized that cerebral hyperglycolysis is involved in the neuroprotection of normobaric oxygen therapy against ischemic stroke. In this study, Sprague-Dawley rats were subjected to either 2-hour middle cerebral artery occlusion followed by 3- or 24-hour reperfusion or to a permanent middle cerebral artery occlusion event. At 2 hours after the onset of ischemia, all rats received either 95% oxygen normobaric oxygen therapy for 3 hours or room air. Compared with room air, normobaric oxygen therapy significantly reduced the infarct volume, neurological deficits, and reactive oxygen species and increased the production of adenosine triphosphate in ischemic rats. These changes were associated with reduced transcriptional and translational levels of the hyperglycolytic enzymes glucose transporter 1 and 3, phosphofructokinase 1, and lactate dehydrogenase. In addition, normobaric oxygen therapy significantly reduced adenosine monophosphate-activated protein kinase mRNA expression and phosphorylated adenosine monophosphate-activated protein kinase protein expression. These findings suggest that normobaric oxygen therapy can reduce hyperglycolysis through modulating the adenosine monophosphate-activated protein kinase signaling pathway and alleviating oxidative injury, thereby exhibiting neuroprotective effects in ischemic stroke. This study was approved by the Institutional Animal Investigation Committee of Capital Medical University (approval No. AEEI-2018-033) on August 13, 2018.
Collapse
Affiliation(s)
- Zhe Cheng
- Department of Neurology, Luhe Hospital, Capital Medical University, Beijing, China
| | - Feng-Wu Li
- China-America Institute of Neuroscience, Luhe Hospital, Capital Medical University, Beijing, China
| | - Christopher R Stone
- Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA
| | - Kenneth Elkin
- Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA
| | - Chang-Ya Peng
- Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA
| | - Redina Bardhi
- Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA
| | - Xiao-Kun Geng
- Department of Neurology; China-America Institute of Neuroscience, Luhe Hospital, Capital Medical University, Beijing, China; Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA
| | - Yu-Chuan Ding
- China-America Institute of Neuroscience, Luhe Hospital, Capital Medical University, Beijing, China; Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA
| |
Collapse
|
12
|
Bardhi R, Lawrence K, Bedford LM, Deirawan H, Moossavi M. Disseminated cryptococcosis presenting with cutaneous involvement in an immunocompromised patient. Dermatol Online J 2020; 26:13030/qt8fv322pr. [PMID: 33423425] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2020] [Accepted: 12/29/2020] [Indexed: 06/12/2023] Open
Abstract
Cryptococcosis is a fungal infection that typically affects immunocompromised patients. It most commonly affects the lungs and may then disseminate to the central nervous system, bone, skin, and adrenal glands. Herein, we describe a 69-year-old man who presented with skin lesions as the initial manifestation of disseminated cryptococcosis. Initial workup led to an assumption that the patient was immunocompetent. Later in the clinical course, idiopathic depletion of CD4 T cells was discovered. This case highlights that disseminated cryptococcosis may present with cutaneous symptoms even when there is no evidence of pulmonary or central nervous system involvement and may be the first sign of an underlying cellular immune dysfunction.
Collapse
Affiliation(s)
| | - Kelsey Lawrence
- Department of Dermatology, Wayne State University, Detroit, MI.
| | | | | | | |
Collapse
|
13
|
Bardhi R, Jairath N, Jairath R, Runge J, Bledea R, Hristov A, Wilcox R, Tsoi L, Patrick M, Tejasvi T. 1096P Clinicopathologic risk factors for large cell transformation in patients with Sezary syndrome. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
14
|
Han W, Liu P, Feng ZD, Ji Y, Zhang ZY, Zhang TL, Bardhi R, Ji ZL. Ratios of lymphocyte and neutrophil to lymphocyte as early predictors of the severity of acute pancreatitis at different age stratifications. Environ Dis 2020. [DOI: 10.4103/ed.ed_35_19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
15
|
Bardhi R, Lawrence K, Bedford LM, Deirawan H, Moossavi M. Disseminated cryptococcosis presenting with cutaneous involvement in an immunocompromised patient. Dermatol Online J 2020. [DOI: 10.5070/d32612051361] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
|